Arbour Group can assist with the assessment of risk, development of procedures and testing required by the FDA to include 21 CFR 820, Quality System Regulation or 21 CFR Part 1271, Human Cells, Tissues and Tissue-based Products (HCT/Ps), as appropriate.
We can deliver a wealth of industry experience and regulatory knowledge to assist with: